Cimoxatone

Cimoxatone
Clinical data
ATC code
  • none
Identifiers
IUPAC name
  • 3-[[4-[5-(methoxymethyl)-2-oxo-oxazolidin-3-yl]phenoxy]methyl]benzonitrile
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.070.537
Chemical and physical data
FormulaC19H18N2O4
Molar mass338.363 g·mol−1
InChI
  • InChI=1S/C19H18N2O4/c1-23-13-18-11-21(19(22)25-18)16-5-7-17(8-6-16)24-12-15-4-2-3-14(9-15)10-20/h2-9,18H,11-13H2,1H3 Y
  • Key:MVVJINIUPYKZHR-UHFFFAOYSA-N Y
 NY (what is this?)  (verify)

Cimoxatone (MD 780515) is a reversible inhibitor of MAO-A (RIMA).[1] It was never marketed.

Cimoxatone has a half-life of 12.4 hours in humans.[2]

See also

References

  1. ^ Nair NP, Ahmed SK, Kin NM, West TE (1995). "Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients". Acta Psychiatr Scand Suppl. 386: 28–35. doi:10.1111/j.1600-0447.1995.tb05921.x. PMID 7717092. S2CID 9100689.
  2. ^ "Cimoxatone: pharmacokinetics of various formulations". InPharma. 427 (1): 6. 1984-03-01. doi:10.1007/BF03314342. ISSN 2230-6056.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.